These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 18972844)

  • 1. Histone deacetylase inhibitors from the rhizomes of Zingiber zerumbet.
    Chung IM; Kim MY; Park WH; Moon HI
    Pharmazie; 2008 Oct; 63(10):774-6. PubMed ID: 18972844
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pomiferin, histone deacetylase inhibitor isolated from the fruits of Maclura pomifera.
    Son IH; Chung IM; Lee SI; Yang HD; Moon HI
    Bioorg Med Chem Lett; 2007 Sep; 17(17):4753-5. PubMed ID: 17662606
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Potentially bioactive two new natural sesquiterpenoids from the rhizomes of Zingiber zerumbet.
    Jang DS; Seo EK
    Arch Pharm Res; 2005 Mar; 28(3):294-6. PubMed ID: 15832816
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bis(4-hydroxybenzyl)sulfide: a sulfur compound inhibitor of histone deacetylase isolated from root extract of Pleuropterus ciliinervis.
    Son IH; Lee SI; Yang HD; Moon HI
    Molecules; 2007 Apr; 12(4):815-20. PubMed ID: 17851433
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MGCD0103, a novel isotype-selective histone deacetylase inhibitor, has broad spectrum antitumor activity in vitro and in vivo.
    Fournel M; Bonfils C; Hou Y; Yan PT; Trachy-Bourget MC; Kalita A; Liu J; Lu AH; Zhou NZ; Robert MF; Gillespie J; Wang JJ; Ste-Croix H; Rahil J; Lefebvre S; Moradei O; Delorme D; Macleod AR; Besterman JM; Li Z
    Mol Cancer Ther; 2008 Apr; 7(4):759-68. PubMed ID: 18413790
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of zerumbone in Zingiber zerumbet Smith as a potent inhibitor of 12-O-tetradecanoylphorbol-13-acetate-induced Epstein-Barr virus activation.
    Murakami A; Takahashi M; Jiwajinda S; Koshimizu K; Ohigashi H
    Biosci Biotechnol Biochem; 1999 Oct; 63(10):1811-2. PubMed ID: 10586508
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Induction of apoptosis by zerumbone isolated from Zingiber zerumbet (L.) Smith in protozoan parasite Leishmania donovani due to oxidative stress.
    Mukherjee D; Singh CB; Dey S; Mandal S; Ghosh J; Mallick S; Hussain A; Swapana N; Ross SA; Pal C
    Braz J Infect Dis; 2016; 20(1):48-55. PubMed ID: 26643969
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Zerumbone from Zingiber zerumbet (L.) smith: a potential prophylactic and therapeutic agent against the cariogenic bacterium Streptococcus mutans.
    Moreira da Silva T; Pinheiro CD; Puccinelli Orlandi P; Pinheiro CC; Soares Pontes G
    BMC Complement Altern Med; 2018 Nov; 18(1):301. PubMed ID: 30424764
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Humulene derivatives from Zingiber zerumbet with the inhibitory effects on lipopolysaccharide-induced nitric oxide production.
    Jang DS; Min HY; Kim MS; Han AR; Windono T; Jeohn GH; Kang SS; Lee SK; Seo EK
    Chem Pharm Bull (Tokyo); 2005 Jul; 53(7):829-31. PubMed ID: 15997145
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeted histone deacetylase inhibition for cancer therapy.
    Vigushin DM; Coombes RC
    Curr Cancer Drug Targets; 2004 Mar; 4(2):205-18. PubMed ID: 15032670
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Class I histone deacetylase-selective novel synthetic inhibitors potently inhibit human tumor proliferation.
    Park JH; Jung Y; Kim TY; Kim SG; Jong HS; Lee JW; Kim DK; Lee JS; Kim NK; Kim TY; Bang YJ
    Clin Cancer Res; 2004 Aug; 10(15):5271-81. PubMed ID: 15297431
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Histone deacetylation in epigenetics: an attractive target for anticancer therapy.
    Mai A; Massa S; Rotili D; Cerbara I; Valente S; Pezzi R; Simeoni S; Ragno R
    Med Res Rev; 2005 May; 25(3):261-309. PubMed ID: 15717297
    [TBL] [Abstract][Full Text] [Related]  

  • 13. KD5170, a novel mercaptoketone-based histone deacetylase inhibitor that exhibits broad spectrum antitumor activity in vitro and in vivo.
    Hassig CA; Symons KT; Guo X; Nguyen PM; Annable T; Wash PL; Payne JE; Jenkins DA; Bonnefous C; Trotter C; Wang Y; Anzola JV; Milkova EL; Hoffman TZ; Dozier SJ; Wiley BM; Saven A; Malecha JW; Davis RL; Muhammad J; Shiau AK; Noble SA; Rao TS; Smith ND; Hager JH
    Mol Cancer Ther; 2008 May; 7(5):1054-65. PubMed ID: 18483295
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exploration of certain 1,3-oxazole- and 1,3-thiazole-based hydroxamic acids as histone deacetylase inhibitors and antitumor agents.
    Anh DT; Hai PT; Huong LT; Park EJ; Jun HW; Kang JS; Kwon JH; Dung DTM; Anh VT; Hue VTM; Han SB; Nam NH
    Bioorg Chem; 2020 Aug; 101():103988. PubMed ID: 32534346
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Design, synthesis and biological evaluation of novel hydroxamates and 2-aminobenzamides as potent histone deacetylase inhibitors and antitumor agents.
    Xie R; Yao Y; Tang P; Chen G; Liu X; Yun F; Cheng C; Wu X; Yuan Q
    Eur J Med Chem; 2017 Jul; 134():1-12. PubMed ID: 28391133
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis of sulfonamides and evaluation of their histone deacetylase (HDAC) activity.
    Oh S; Moon HI; Son IH; Jung JC; Avery MA
    Molecules; 2007 May; 12(5):1125-35. PubMed ID: 17873846
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Standardized ethanol extract, essential oil and zerumbone of Zingiber zerumbet rhizome suppress phagocytic activity of human neutrophils.
    Akhtar NMY; Jantan I; Arshad L; Haque MA
    BMC Complement Altern Med; 2019 Nov; 19(1):331. PubMed ID: 31752812
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of inhibitors of histone deacetylase on the induction of cell differentiation in murine and human erythroleukemia cell lines.
    Wittich S; Scherf H; Xie C; Heltweg B; Dequiedt F; Verdin E; Gerhäuser C; Jung M
    Anticancer Drugs; 2005 Jul; 16(6):635-43. PubMed ID: 15930892
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Histone deacetylase inhibitors radiosensitize human melanoma cells by suppressing DNA repair activity.
    Munshi A; Kurland JF; Nishikawa T; Tanaka T; Hobbs ML; Tucker SL; Ismail S; Stevens C; Meyn RE
    Clin Cancer Res; 2005 Jul; 11(13):4912-22. PubMed ID: 16000590
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Design, synthesis, and biological evaluation of indole-based hydroxamic acid derivatives as histone deacetylase inhibitors.
    Jiang BE; Hu J; Liu H; Liu Z; Wen Y; Liu M; Zhang HK; Pang X; Yu LF
    Eur J Med Chem; 2022 Jan; 227():113893. PubMed ID: 34656899
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.